Clinical trials in children.

Safety and efficacy data on many medicines used in children are surprisingly scarce. As a result children are sometimes given ineffective medicines or medicines with unknown harmful side effects. Better and more relevant clinical trials in children are needed to increase our knowledge of the effects of medicines and to prevent the delayed or non-use of beneficial therapies. Clinical trials provide reliable evidence of treatment effects by rigorous controlled testing of interventions on human subjects. Paediatric trials are more challenging to conduct than trials in adults because of the paucity of funding, uniqueness of children and particular ethical concerns. Although current regulations and initiatives are improving the scope, quantity and quality of trials in children, there are still deficiencies that need to be addressed to accelerate radically equitable access to evidence-based therapies in children.

[1]  Shinya Ito,et al.  Challenges for drug studies in children: CYP3A phenotyping as example. , 2009, Drug discovery today.

[2]  P. A. Kelly,et al.  Readability of pediatric biomedical research informed consent forms. , 1990, Pediatrics.

[3]  N. Fost.  Ethical issues in research and innovative therapy in children with mood disorders , 2001, Biological Psychiatry.

[4]  H. Bauchner,et al.  Child Versus Adult Research: The Gap in High-Quality Study Design , 2008, Pediatrics.

[5]  E. Shuster.  Fifty years later: the significance of the Nuremberg Code. , 1997, The New England journal of medicine.

[6]  D. J. Davis,et al.  Parental preferences for neonatal resuscitation research consent: a pilot study , 2005, Journal of Medical Ethics.

[7]  C. C. Bailey,et al.  Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X , 1995, The Lancet.

[8]  H. Sammons.  Ethical issues of clinical trials in children: a European perspective , 2009, Archives of Disease in Childhood.

[9]  Jonathan C. Craig,et al.  Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review , 2010, PLoS medicine.

[10]  G. Morrow,et al.  Behavioral aspects of clinical trials: An integrated framework from behavior theory , 1994, Cancer.

[11]  S. Johnson,et al.  Offering a Randomized Mai of Intensive Therapy for IDDM to Adolescents: Reasons for refusal, patient characteristics, and recruiter effects , 1998, Diabetes Care.

[12]  C. Mathers.  Global Burden of Disease Among Women, Children, and Adolescents , 2009 .

[13]  M. Farrell,et al.  Lessons from the E-Ferol tragedy. , 1986, Pediatrics.

[14]  C. Stiller,et al.  Trends in survival for childhood cancer in Britain diagnosed 1971-85. , 1990, British Journal of Cancer.

[15]  H. Shirkey.  Therapeutic orphans. , 1968, The Journal of pediatrics.

[16]  D. Elbourne,et al.  Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial. , 1997, Social science & medicine.

[17]  H. Bastian,et al.  Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up? , 2010, PLoS medicine.

[18]  T. F. Ackerman.  The Ethics of Drug Research in Children , 2001, Paediatric drugs.

[19]  N Colabianchi,et al.  Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Cody S. Olsen,et al.  Utility of Plain Radiographs in Detecting Traumatic Injuries of the Cervical Spine in Children , 2012, Pediatric emergency care.

[21]  G. Koren,et al.  Ethical Issues in Including Pediatric Cancer Patients in Drug Development Trials , 2002, Paediatric drugs.

[22]  E. Royle,et al.  A review of randomised controlled trials published inArchives of Disease in Childhood from 1982–96 , 1998, Archives of disease in childhood.

[23]  D. Rosenstein,et al.  The therapeutic orientation to clinical trials. , 2003, The New England journal of medicine.

[24]  M. Tobin,et al.  Beyond "misunderstanding": written information and decisions about taking part in a genetic epidemiology study. , 2007, Social science & medicine.

[25]  Edward Mills,et al.  Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials. , 2009, Developing world bioethics.

[26]  C L Soskolne,et al.  Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. , 1984, The New England journal of medicine.

[27]  P. Hill,et al.  Off licence and off label prescribing in children: litigation fears for physicians , 2005, Archives of Disease in Childhood.

[28]  David Baddeley,et al.  4D Super-Resolution Microscopy with Conventional Fluorophores and Single Wavelength Excitation in Optically Thick Cells and Tissues , 2011, PloS one.

[29]  G. Howard,et al.  Clinical Trial Design Issues: At Least 10 Things You Should Look For in Clinical Trials , 2006, Journal of clinical pharmacology.

[30]  J. Salazar.  Pediatric clinical trial experience: government, child, parent and physician’s perspective , 2003, The Pediatric infectious disease journal.

[31]  D. Brasseur,et al.  Development of medicines for children in Europe: ethical implications. , 2005, Paediatric respiratory reviews.

[32]  I. Choonara,et al.  Unlicensed and off label drug use in paediatric wards: prospective study , 1998, BMJ.

[33]  M. Greener.  Bitter medicine , 2008, EMBO reports.

[34]  N. Ruperto.  Classification Criteria and Diagnostic Tests for Vasculitides , 2012, The Journal of Rheumatology.

[35]  P. Williamson,et al.  What parents think about being approached about children’s trials, how this differs from what practitioners expect, and what this tells us about enhancing recruitment , 2011, Trials.

[36]  Robert M Califf,et al.  Peer-reviewed publication of clinical trials completed for pediatric exclusivity. , 2006, JAMA.

[37]  B. Wilfond,et al.  When do the federal regulations allow placebo-controlled trials in children? , 2003, The Journal of pediatrics.

[38]  G. Swanson,et al.  Recruiting minorities into clinical trials: toward a participant-friendly system. , 1995, Journal of the National Cancer Institute.

[39]  K. M. Taylor.  The doctor's dilemma: physician participation in randomized clinical trials. , 1985, Cancer treatment reports.

[40]  J. Ioannidis,et al.  Comparative effectiveness of medical interventions in adults versus children. , 2010, The Journal of pediatrics.

[41]  L. Ries,et al.  Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .

[42]  F. Morales-Olivas,et al.  Clinical trials in children. , 2006, Reviews on recent clinical trials.

[43]  P M Wax,et al.  Elixirs, Diluents, and the Passage of the 1938 Federal Food, Drug and Cosmetic Act , 1995, Annals of Internal Medicine.

[44]  D J Torgerson,et al.  Pragmatic trials: lab meets bedside , 2019, The British journal of dermatology.

[45]  D. Tibboel,et al.  Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations , 2007, Expert opinion on pharmacotherapy.

[46]  S. Conroy,et al.  Drug trials in children: problems and the way forward. , 2000, British journal of clinical pharmacology.

[47]  K. Taylor,et al.  Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  U. Simeoni,et al.  Clinical research in newborn infants: difficulties and specificity , 2011, European Journal of Clinical Pharmacology.

[49]  Roderik F. Viergever,et al.  The Quality of Registration of Clinical Trials , 2011, PloS one.

[50]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, The New England journal of medicine.

[51]  Phyllis N Butow,et al.  Clinical trials in children , 2004, The Lancet.

[52]  C. Walsh,et al.  Minority Children in Pediatric Research , 2003, American Journal of Law & Medicine.

[53]  A. Davidson,et al.  Ethics and medical research in children , 2009, Paediatric anaesthesia.

[54]  I. Choonara,et al.  Clinical trials of medication in children, 1996–2002 , 2005, European Journal of Clinical Pharmacology.

[55]  J. Flynn.  Ethics of placebo use in pediatric clinical trials: the case of antihypertensive drug studies. , 2003, Hypertension.

[56]  C. L. Baeyer.  Children’s self-reports of pain intensity: Scale selection, limitations and interpretation , 2006 .

[57]  G. Permanand,et al.  The EU’s new paediatric medicines legislation: serving children’s needs? , 2007, Archives of Disease in Childhood.

[58]  Terri Voepel-Lewis,et al.  Do They Understand? (Part I): Parental Consent for Children Participating in Clinical Anesthesia and Surgery Research , 2003, Anesthesiology.

[59]  Thomas F. Smith,et al.  Recruitment of participants in the childhood Asthma Management Program (CAMP). I. Description of methods: Childhood Asthma Management Program Research Group. , 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.

[60]  S. Rosenzweig,et al.  Ethics of clinical trials. , 2000, The New England journal of medicine.

[61]  L. Ross,et al.  Ethical issues in pediatric trials. , 2001, American heart journal.

[62]  T. Johnson.  Modelling approaches to dose estimation in children. , 2005, British journal of clinical pharmacology.

[63]  B. A. Noah.  Just a Spoonful of Sugar: Drug Safety for Pediatric Populations , 2009, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[64]  M. Schreiner.  Paediatric clinical trials: redressing the imbalance , 2003, Nature Reviews Drug Discovery.

[65]  P. Richards.  Health research , 1954, Nature.

[66]  E. Kodish,et al.  Improving Informed Consent: Suggestions From Parents of Children With Leukemia , 2007, Pediatrics.

[67]  H. Sather,et al.  Parents' perceptions of randomization in pediatric clinical trials. Children Cancer Group. , 1999, Cancer practice.

[68]  N. Cranswick,et al.  Clinical Trials, Ethical Issues and Patient Recruitment: an Australian Perspective , 2003 .

[69]  C. Soskolne,et al.  Physician response to informed consent regulations for randomized clinical trials , 1987, Cancer.

[70]  A. Glenny,et al.  Audit to monitor the uptake of national mouth care guidelines for children and young people being treated for cancer , 2011, Supportive Care in Cancer.

[71]  Jeffrey L Kaufman.  Protecting research subjects. , 2002, The New England journal of medicine.

[72]  E. Roon,et al.  Low quality of reporting adverse drug reactions in paediatric randomised controlled trials , 2010, Archives of Disease in Childhood.

[73]  L. Kopelman.  Children as research subjects: a dilemma. , 2000, The Journal of medicine and philosophy.

[74]  R. Souhami,et al.  Clinicians' attitudes to clinical trials of cancer therapy. , 1997, European journal of cancer.

[75]  B. Vandermeer,et al.  Controlled Trials in Children: Quantity, Methodological Quality and Descriptive Characteristics of Pediatric Controlled Trials Published 1948-2006 , 2010, PloS one.

[76]  J. Wilson,et al.  An update on the therapeutic orphan. , 1999, Pediatrics.

[77]  P. Caldwell,et al.  The ethics of paediatric research , 2011, Journal of paediatrics and child health.

[78]  E. Steyerberg,et al.  Informed consent, parental awareness, and reasons for participating in a randomised controlled study , 1998, Archives of disease in childhood.

[79]  S. Murphy,et al.  The national impact of clinical cooperative group trials for pediatric cancer. , 1995, Medical and pediatric oncology.

[80]  R. Dagher,et al.  Good clinical practice and the conduct of clinical studies in pediatric oncology. , 2008, Pediatric clinics of North America.

[81]  B. Galland,et al.  Participation in research: Informed consent, motivation and influence , 2001, Journal of paediatrics and child health.

[82]  K. Hoppu.  Can we get the necessary clinical trials in children and avoid the unnecessary ones? , 2009, European Journal of Clinical Pharmacology.

[83]  Y. Thong,et al.  The social filter effect of informed consent in clinical research. , 1991, Pediatrics.

[84]  H. Bisgaard,et al.  Respiratory medicines for children: current evidence, unlicensed use and research priorities , 2009, European Respiratory Journal.

[85]  J. Flynn.  Successes and shortcomings of the Food and Drug Modernization Act. , 2003, American journal of hypertension.

[86]  B. Pollock,et al.  Childhood cancer in the united states: A geographical analysis of cases from the Pediatric Cooperative Clinical Trials Groups , 1996, Cancer.

[87]  G. Kearns,et al.  Considerations in the Rational Design and Conduct of Phase I/II Pediatric Clinical Trials: Avoiding the Problems and Pitfalls , 2007, Clinical pharmacology and therapeutics.

[88]  E. Cohen,et al.  An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. , 2007, Journal of clinical epidemiology.

[89]  F. Rocchi,et al.  The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. , 2011, Pharmacological research.

[90]  R. Smyth,et al.  Research in children: ethical and scientific aspects , 1999, The Lancet.

[91]  B. Young,et al.  Standard 1: Consent and Recruitment , 2012, Pediatrics.

[92]  J. Wit,et al.  Stimulation programs for pediatric drug research – do children really benefit? , 2007, European Journal of Pediatrics.

[93]  S. Bavdekar.  Pediatric clinical trials , 2013, Perspectives in clinical research.

[94]  A. Coates,et al.  Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[95]  Childhood , 2010, The Classical Review.

[96]  H. Shirkey.  Editorial Comment: Therapeutic Orphans , 1999 .

[97]  J. Boos,et al.  Randomized clinical trials in children--ethical and methodological issues. , 2010, Current pharmaceutical design.

[98]  R. Chang,et al.  Prerandomization: an alternative to classic randomization. The effects on recruitment in a controlled trial of arthroscopy for osteoarthrosis of the knee. , 1990, The Journal of bone and joint surgery. American volume.

[99]  R. Shaddy,et al.  Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations , 2010, Pediatrics.

[100]  Jenny L Donovan,et al.  Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial , 1998, BMJ.

[101]  R. Chesney,et al.  Is pediatric labeling really necessary? , 1999, Pediatrics.

[102]  D. Murphy,et al.  Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. , 2003, JAMA.

[103]  D. Asch,et al.  Physicians’ preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs , 2002, Journal of General Internal Medicine.

[104]  B. Anderson,et al.  Common errors of drug administration in infants: causes and avoidance. , 1999, Paediatric drugs.

[105]  L. Hartling,et al.  Children Are Not Just Small Adults: The Urgent Need for High-Quality Trial Evidence in Children , 2008, PLoS medicine.

[106]  I. Choonara,et al.  Safety in paediatric clinical trials – a 7‐year review , 2008, Acta paediatrica.

[107]  B. Schmidt,et al.  Do sick newborn infants benefit from participation in a randomized clinical trial , 1999 .

[108]  Eric L Eisenstein,et al.  Economic return of clinical trials performed under the pediatric exclusivity program. , 2007, JAMA.

[109]  W. Bleyer.  Re: recruiting minorities into clinical trials: toward a participant-friendly system. , 1996, Journal of the National Cancer Institute.

[110]  T. Meade,et al.  Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study , 1999, BMJ.

[111]  Louette R. Johnson Lutjens.  Research , 2006 .

[112]  O. Dulac,et al.  Trials in children , 2001, Epilepsy Research.

[113]  A. Martini,et al.  Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO) , 2011, Archives of Disease in Childhood.

[114]  R. Smyth,et al.  Making a difference: the clinical research programme for children , 2007, Archives of Disease in Childhood.

[115]  Terri Voepel-Lewis,et al.  Participation of Children in Clinical Research: Factors that Influence a Parent's Decision to Consent , 2003, Anesthesiology.

[116]  G. Swingler,et al.  Children in reviews: Methodological issues in child-relevant evidence syntheses , 2005, BMC pediatrics.

[117]  A. Windebank,et al.  Lessons from the Salk Polio Vaccine: Methods for and Risks of Rapid Translation , 2010, Clinical and translational science.

[118]  K J Rothman,et al.  The continuing unethical use of placebo controls. , 1994, The New England journal of medicine.

[119]  A. Brooke.  Paediatric clinical research manual , 2006 .

[120]  W. Curran.  The thalidomide tragedy in Germany: the end of a historic medicolegal trial. , 1971, The New England journal of medicine.

[121]  Martin Stanulla,et al.  Treatment of childhood acute lymphoblastic leukemia. , 2009, Seminars in hematology.

[122]  M. Simar,et al.  Pediatric Drug Development: The International Conference on Harmonization Focus on Clinical Investigations in Children , 2000 .

[123]  D. Hirtz,et al.  Clinical trials in children--How are they implemented? , 2006, Pediatric neurology.

[124]  F. Bellanti,et al.  Modelling and simulation as research tools in paediatric drug development , 2011, European Journal of Clinical Pharmacology.

[125]  J. Abbott,et al.  Quality of Life in Children and Adolescents with Cystic Fibrosis , 2003, Paediatric drugs.

[126]  C. V. von Baeyer,et al.  Children's self-reports of pain intensity: scale selection, limitations and interpretation. , 2006, Pain research & management.

[127]  H. Milgrom,et al.  Ethical considerations in research involving children , 2005, Current allergy and asthma reports.

[128]  C. Tishler,et al.  Pediatric Drug-Trial Recruitment: Enticement Without Coercion , 2011, Pediatrics.

[129]  C. Pandolfini,et al.  Registration of trials in children: update of current international initiatives , 2009, Archives of Disease in Childhood.

[130]  Taylor Km.  Physician participation in a randomized clinical trial for ocular melanoma. , 1992 .

[131]  W. Silverman,et al.  A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. , 1956, Pediatrics.

[132]  S. Mason,et al.  Obtaining informed consent to neonatal randomised controlled trials: interviews with parents and clinicians in the Euricon study , 2000, The Lancet.

[133]  D. Elbourne,et al.  Zelen randomization: attitudes of parents participating in a neonatal clinical trial. , 1998, Controlled clinical trials.

[134]  R. Smyth,et al.  Research with children , 2001, BMJ : British Medical Journal.

[135]  C. Grady,et al.  The ethics of paying for children's participation in research. , 2002, The Journal of pediatrics.

[136]  J. Meaux,et al.  Balancing recruitment and protection: children as research subjects. , 2001, Issues in comprehensive pediatric nursing.

[137]  Y. Thong,et al.  Parental perceptions and attitudes about informed consent in clinical research involving children. , 1995, Social science & medicine.

[138]  M. Spedding,et al.  Clinical trials in neonates: ethical issues. , 2007, Seminars in fetal & neonatal medicine.

[139]  N. Singhal,et al.  Parents' Perceptions of Research With Newborns , 2002, Journal of Perinatology.

[140]  C. Fisher,et al.  A Goodness-of-Fit Approach to Informed Consent for Pediatric Intervention Research , 2008 .

[141]  T. Garrington,et al.  Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials , 2008, Current oncology reports.

[142]  A Bond,et al.  Factors affecting general practitioners' recruitment of patients into a prospective study. , 1993, Family practice.

[143]  B. Starfield,et al.  Assessment of risk in research on children. , 1981, The Journal of pediatrics.

[144]  G. Kearns,et al.  The status of paediatric medicines initiatives around the world—what has happened and what has not? , 2011, European Journal of Clinical Pharmacology.

[145]  P. Williamson,et al.  Parents’ Agendas in Paediatric Clinical Trial Recruitment Are Different from Researchers’ and Often Remain Unvoiced: A Qualitative Study , 2013, PloS one.

[146]  R. Steinbrook.  Testing medications in children. , 2002, The New England journal of medicine.

[147]  C. Tesch,et al.  Clinical Trial Disclosure: Global Overview and Implications of New Laws and Guidelines , 2010 .

[148]  K. Taylor,et al.  Integrating conflicting professional roles: physician participation in randomized clinical trials. , 1992, Social science & medicine.

[149]  W. McCaskill-Stevens,et al.  Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[150]  M. Kelner,et al.  Interpreting physician participation in randomized clinical trials: the Physician Orientation Profile. , 1987, Journal of health and social behavior.

[151]  M. Laughon,et al.  Innovative clinical trial design for pediatric therapeutics , 2011, Expert review of clinical pharmacology.

[152]  J. Hodgman,et al.  Fatal circulatory collapse in premature infants receiving chloramphenicol. , 1959, The New England journal of medicine.

[153]  B. Schmidt,et al.  Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomized clinical trials. , 2001 .

[154]  S. Cohen,et al.  The Pediatric Pharmacology Research Unit (PPRU) Network and its role in meeting pediatric labeling needs. , 1999, Pediatrics.

[155]  J. Langley,et al.  Parental willingness to enter a child in a controlled vaccine trial. , 1998, Clinical and investigative medicine. Medecine clinique et experimentale.

[156]  J. Byers,et al.  Gene Therapy in the Post-Gelsinger Era , 2002, JONA'S healthcare law, ethics and regulation.

[157]  Roger Dobson,et al.  Lump sums for children taking part in research may distort parents' judgment , 2002, BMJ : British Medical Journal.

[158]  Florence T. Bourgeois,et al.  Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden , 2012, Pediatrics.

[159]  P. Butow,et al.  Pediatricians' attitudes toward randomized controlled trials involving children. , 2002, The Journal of pediatrics.

[160]  I. Choonara,et al.  Published Pediatric Randomized Drug Trials in Developing Countries, 1996–2002 , 2010, Paediatric drugs.

[161]  D. Horner,et al.  The ethics of clinical trials , 2009 .

[162]  Christiane,et al.  WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects , 2001, Journal of postgraduate medicine.

[163]  D. Stryer,et al.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. , 2003, JAMA.

[164]  J. Zupancic,et al.  Determinants of parental authorization for involvement of newborn infants in clinical trials. , 1997, Pediatrics.

[165]  Maria Grazia Valsecchi,et al.  Improving recruitment to clinical trials for cancer in childhood. , 2008, The Lancet. Oncology.

[166]  Phyllis N Butow,et al.  Parents' attitudes to children's participation in randomized controlled trials. , 2003, The Journal of pediatrics.

[167]  C. Grady,et al.  What's the price of a research subject? Approaches to payment for research participation. , 1999, The New England journal of medicine.

[168]  L. Hartling,et al.  StaR Child Health: an initiative for RCTs in children , 2009, The Lancet.

[169]  T. Richards.  Developed countries should not impose ethics on other countries , 2002, BMJ : British Medical Journal.

[170]  I. Choonara,et al.  A systematic review of paediatric randomised controlled drug trials published in 2007 , 2010, Archives of Disease in Childhood.

[171]  C. Stiller,et al.  Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[172]  B. Warady,et al.  Clinical research in pediatric nephrology: challenges, and strategies to address them. , 2009, Journal of nephrology.

[173]  Paula R Williamson,et al.  A Systematic Review of Studies That Aim to Determine Which Outcomes to Measure in Clinical Trials in Children , 2008, PLoS medicine.

[174]  Maurizio Bonati,et al.  Survey of unlicensed and off label drug use in paediatric wards in European countries , 2000, BMJ : British Medical Journal.

[175]  B. Young,et al.  How do parents experience being asked to enter a child in a randomised controlled trial? , 2009, BMC medical ethics.

[176]  R. Simes,et al.  Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists. , 1999, The Australian and New Zealand journal of surgery.

[177]  L. Dawson,et al.  The Salk Polio Vaccine Trial of 1954: risks, randomization and public involvement in research , 2004, Clinical trials.

[178]  L. Hartling,et al.  StaR Child Health: Developing Evidence-Based Guidance for the Design, Conduct, and Reporting of Pediatric Trials , 2012, Pediatrics.

[179]  A. Rademaker,et al.  Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[180]  J. Walterspiel.  Informed consent: influence on patient selection among critically ill premature infants. , 1990, Pediatrics.

[181]  P. Glasziou,et al.  Avoidable waste in the production and reporting of research evidence. , 2009, Obstetrics and gynecology.

[182]  T. Ernest,et al.  Developing paediatric medicines: identifying the needs and recognizing the challenges , 2007, The Journal of pharmacy and pharmacology.

[183]  K. Pritchard-Jones.  Clinical trials for children with cancer in Europe - still a long way from harmonisation: a report from SIOP Europe. , 2008, European journal of cancer.